When Does Type 2 Diabetes Attack the Liver?
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
The latest news and updates about NYSCF and our collaborators
The Context: When someone builds up excess fat around their liver, they can develop a condition called non-alcoholic fatty liver disease (NAFLD). Those with type 2...
The Context: We don’t need to tell you that the world is a stressful place – and everyone will have to overcome extreme challenges at some...
Even if you don’t know Derrick Rossi, PhD, you almost certainly know Moderna: the company behind mRNA vaccine technology he co-founded that is protecting millions from...
This November, National Diabetes Month yielded some early holiday cheer as the FDA approved an exciting preventative treatment for type 1 diabetes (T1D). This work was...
Why do some people get PTSD and others don’t? And what can stem cells tell us about how to develop better therapies? Understanding why certain individuals...
On October 18th and 19th, we hosted the seventeenth annual NYSCF Conference at The Rockefeller University, convening in person again after two years of virtual meetings....
A major hallmark of Parkinson’s disease is the loss of dopamine-producing neurons in the brain, which in turn causes patients to lose motor control abilities. NYSCF...
“I believe in the power of stem cell science to change the lives of patients and their families,” remarked NYSCF Interim CEO Derrick Rossi, PhD, as...
This October, family, friends, and colleagues gathered to celebrate the life of NYSCF Founding CEO Susan L. Solomon, JD, who passed away last month after a...
The New York Stem Cell Foundation (NYSCF) announced Dr. Derrick Rossi, a member of the NYSCF Board of Directors and co-founder of Moderna, as Interim CEO...
The Context: Neuropsychiatric disorders are notoriously hard to study due to their complexity and the inaccessibility of human brain tissue for experimentation. However, recent advances in...
The Context: Perhaps you’ve noticed that some people seem to get COVID-19 more easily than others. This could be due to differences in our genomes. Our...
First induced pluripotent stem cell model of PTSD offers insights into underlying genetics and opportunities for new therapies (Sign up for our upcoming webinar on November...
The Context: Post-traumatic stress disorder (PTSD) affects more than 12 million people worldwide. Only a minority of people exposed to trauma will end up with PTSD,...
The New York Stem Cell Foundation (NYSCF) today announced the 2022 class of NYSCF – Robertson Investigators, welcoming six outstanding stem cell researchers and neuroscientists into...
The New York Stem Cell Foundation’s (NYSCF) 16th Annual Conference convenes global leaders in stem cell research to present their latest progress towards treatments and cures...
There are many ways to pursue a career in STEM, and not all of them involve becoming an academic. Last month, as part of the NYSCF...
Science is much more than textbooks and lectures: it’s dynamic, interdisciplinary, and hands-on. For the past three summers, NYSCF has brought talented young minds together for...
For Iva Knezevic, a tour of NYSCF’s labs at age 14 sparked an interest in stem cells and a yearning to use them to better understand...
NEW YORK, NY (September 9, 2022) – The New York Stem Cell Foundation (NYSCF) today announced the death of its Chief Executive Officer and Co-Founder, Susan...
The New York Stem Cell Foundation mourns the loss of Board Director Emeritus John L. Eastman, who, with his wife Jodie, was a founding supporter of...
The New York Stem Cell Foundation is deeply saddened by the death of Junior Leadership Council member Sabrina Bertucci, who received the NYSCF Stem Cell Hero...
NYSCF mourns the passing of our Leadership Council Member Julian Robertson. Since 2010, Julian and the Robertson Foundation have been transformational partners in several of NYSCF’s...
Spencer Haws might be relatively new to the field of stem cells, but he’s diving in head first to understand a disease with few treatment options:...
In NYSCF – Druckenmiller Postdoctoral Fellow Sophie Morgani’s lab, run by Philipp Leucht at the NYU Grossman School of Medicine, there’s a bit of a curse....